75287 Dupilumab Monotherapy Improves Xerosis and Dyspigmentation in Patients with Skin of Color and Moderate-to-Severe Atopic Dermatitis
Journal of the American Academy of Dermatology · 2026-07 · 95 (1) · AB168
DOI: 10.1016/j.jaad.2026.04.693 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Academy of Dermatology, 2026-07. Verfasst von Andrew Alexis und 9 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Alexis, A., Markowitz, O., Mayo, T., Callender, V., Levit, N., Xia, C., Chuang, C., Shumel, B., Wang, Z., & Hartford, C. (2026). 75287 Dupilumab Monotherapy Improves Xerosis and Dyspigmentation in Patients with Skin of Color and Moderate-to-Severe Atopic Dermatitis. Journal of the American Academy of Dermatology, 95(1), AB168. https://doi.org/10.1016/j.jaad.2026.04.693
Vancouver
Alexis A, Markowitz O, Mayo T, Callender V, Levit N, Xia C, et al. 75287 Dupilumab Monotherapy Improves Xerosis and Dyspigmentation in Patients with Skin of Color and Moderate-to-Severe Atopic Dermatitis. Journal of the American Academy of Dermatology. 2026;95(1):AB168. doi:10.1016/j.jaad.2026.04.693
BibTeX
@article{Alexis2026,
author = {Alexis, Andrew and Markowitz, Orit and Mayo, Tiffany and Callender, Valerie and Levit, Noah and Xia, Changming and Chuang, Chien-Chia and Shumel, Brad and Wang, Zhixiao and Hartford, Christopher},
title = {75287 Dupilumab Monotherapy Improves Xerosis and Dyspigmentation in Patients with Skin of Color and Moderate-to-Severe Atopic Dermatitis},
journal = {Journal of the American Academy of Dermatology},
year = {2026},
volume = {95},
number = {1},
pages = {AB168},
doi = {10.1016/j.jaad.2026.04.693}
}
EUVIMED